US Bancorp
MXCT icon

US Bancorp’s MaxCyte MXCT Stock Holding History

US Bancorp’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-86,700
Closed -$137K – 4149
2025
Q3 		$137K Hold
86,700
– – ﹤0.01% 2205
2025
Q2 		$189K Hold
86,700
– – ﹤0.01% 2046
2025
Q1 		$237K Sell
86,700
-486
-0.6% -$1.92K ﹤0.01% 1899
2024
Q4 		$363K Sell
87,186
-7,989
-8% -$30.2K ﹤0.01% 1681
2024
Q3 		$370K Sell
95,175
-1,025
-1% -$4.32K ﹤0.01% 1677
2024
Q2 		$377K Buy
96,200
+348
+0.4% +$1.5K ﹤0.01% 1659
2024
Q1 		$402K Buy
95,852
+86,809
+960% +$408K ﹤0.01% 1625
2023
Q4 		$42.5K Buy
9,043
+7,246
+403% +$28.2K ﹤0.01% 2755
2023
Q3 		$5.61K Buy
1,797
+178
+11% +$716 ﹤0.01% 3395
2023
Q2 		$7.43K Buy
1,619
+957
+145% +$4.4K ﹤0.01% 3364
2023
Q1 		$3.28K Buy
+662
New +$3.26K ﹤0.01% 3646

Other funds holding MXCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

US Bancorp's MXCT Position: Q4 2025 in Review

US Bancorp sold out of MaxCyte (MXCT) in Q4 2025, closing a stake of 86,700 shares — an estimated $137K sold.

US Bancorp first reported a position in MXCT in Q1 2023 and held it in 11 quarters. The position peaked at $402K in Q1 2024. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.

  • US Bancorp reported no remaining MaxCyte position as of Q4 2025 after selling out during the quarter.
  • US Bancorp sold 86,700 MaxCyte shares in Q4 2025, an estimated $137K.
  • US Bancorp first reported a position in MaxCyte in Q1 2023 and held it in 11 quarters.
  • US Bancorp's MaxCyte position peaked at $402K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.

Based on US Bancorp's 13F filing for Q4 2025, filed 30 Jan 2026.